ALLMedicine™ Cholangitis Center
Research & Reviews 3,305 results
https://doi.org/10.1016/j.jhep.2022.06.014
Journal of Hepatology; Huang B, Lyu Z et. al.
Jun 27th, 2022 - PDC-E2 specific CD8+ T cells play a leading role in biliary destruction in PBC. However, there are limited data on characterization of these autoantigen specific CD8+ T cells, particularly in liver. Here we aimed to identify the pathogenic intrahe...
https://doi.org/10.1016/j.transproceed.2022.03.041
Transplantation Proceedings; Trevizoli NC, Obeid EJ et. al.
Jun 27th, 2022 - The association between ulcerative colitis (UC) and primary sclerosing cholangitis has been described for several years and can be classified as having a distinct disease phenotype from inflammatory bowel diseases (IBD). The simultaneous occurrenc...
https://doi.org/10.1016/j.jhep.2022.05.044
Journal of Hepatology; Labiano I, Agirre-Lizaso A et. al.
Jun 25th, 2022 - Cholestatic liver injury triggers a wound healing response orchestrated by Kupffer cells (KCs), hepatic stellate cells (HSCs) and other immune cells that leads to peribiliary fibrosis and disease progression. Inflammation is central, particularly ...
https://clinicaltrials.gov/ct2/show/NCT00001971
Jun 24th, 2022 - This is a general clinical research protocol to allow for evaluation, investigation and long-term follow up of patients who have an acute or chronic liver disease. The protocol is designed to study the natural history and pathogenesis of various l...
https://clinicaltrials.gov/ct2/show/NCT01174121
Jun 24th, 2022 - Background: Metastatic digestive tract cancers, in particular esophageal, gastric, pancreatic and hepatobiliary carcinomas, are associated with poor survival beyond five years and poor response to existing therapies. Data from the National Cancer ...
Guidelines 23 results
https://doi.org/10.1016/j.jhep.2022.05.011
Journal of Hepatology; ,
Jun 24th, 2022 - EASL Clinical Practice Guidelines on Sclerosing Cholangitis.|2022| , ,|
https://doi.org/10.1016/j.clinre.2021.101770
Clinics and Research in Hepatology and Gastroenterology; Corpechot C, Heurgue A et. al.
Aug 1st, 2021 - Primary biliary cholangitis (PBC) is a chronic inflammatory disease of the intra-hepatic bile ducts [1]. It is characterised biologically by chronic cholestasis associated with the presence of specific autoantibodies, and histologically by lesions...
https://doi.org/10.1016/j.clinre.2021.101775
Clinics and Research in Hepatology and Gastroenterology; Chazouillères O, Potier P et. al.
Aug 1st, 2021 - Primary sclerosing cholangitis (PSC) is a rare and chronic cholestatic liver disease of unknown cause commonly associated with inflammatory bowel disease (IBD) and characterized by progressive obliterative fibro-inflammation of the biliary tree. A...
https://doi.org/10.1016/j.gie.2020.12.032
Gastrointestinal Endoscopy; Buxbaum JL, Buitrago C et. al.
May 24th, 2021 - Cholangitis is a GI emergency requiring prompt recognition and treatment. The purpose of this document from the American Society for Gastrointestinal Endoscopy's (ASGE) Standards of Practice Committee is to provide an evidence-based approach for m...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665406
Journal of Crohn's & Colitis; Ng SC, Mak JWY et. al.
Oct 22nd, 2020 - Endoscopy is an essential component in the management of inflammatory bowel disease [IBD]. There is a risk of SARS-CoV-2 transmission during endoscopic procedures. The International Organization for the study of IBD [IOIBD] has developed 11 positi...
Drugs 8 results see all →
Clinicaltrials.gov 314 results
https://clinicaltrials.gov/ct2/show/NCT01174121
Jun 24th, 2022 - Background: Metastatic digestive tract cancers, in particular esophageal, gastric, pancreatic and hepatobiliary carcinomas, are associated with poor survival beyond five years and poor response to existing therapies. Data from the National Cancer ...
https://clinicaltrials.gov/ct2/show/NCT04685200
Jun 24th, 2022 - In this single-site, small-scale prospective natural history study, we intend to recruit up to 40 patients with PSC diagnosed by standard clinical, biochemical, or imaging features (including up to 30 with a known diagnosis of IBD) and up to 90 co...
https://clinicaltrials.gov/ct2/show/NCT00001971
Jun 24th, 2022 - This is a general clinical research protocol to allow for evaluation, investigation and long-term follow up of patients who have an acute or chronic liver disease. The protocol is designed to study the natural history and pathogenesis of various l...
https://clinicaltrials.gov/ct2/show/NCT03995212
Jun 21st, 2022 - This study will consist of a Screening Visit, a 7-day Run-in Period, a 16-week Treatment Period, and a Follow-up Visit (approximately 7-10 days after the last dose of study drug). Informed consent will be obtained prior to performing any study-spe...
https://clinicaltrials.gov/ct2/show/NCT02196935
Jun 15th, 2022 - AIMS A) Characterize unusual disease and pathologic presentations which require endoscopic treatment in a large safety net hospital B) To study the impact of EUS and ERCP on the management of these patients. C) Analyze how EUS and ERCP results cor...
News 296 results
https://www.medscape.com/viewarticle/974779
May 27th, 2022 - Patients with acute cholangitis are twice as likely to be readmitted within 30 days if they don't get a cholecystectomy in the same hospital admission for which they get biliary decompression, researchers say. The readmissions result mostly from s...
https://www.medpagetoday.com/gastroenterology/inflammatoryboweldisease/97447
Mar 1st, 2022 - Inflammatory bowel disease (IBD) patients diagnosed with colorectal cancer (CRC) had better cancer outcomes when they had undergone a recent surveillance colonoscopy, a retrospective study of military veterans found. In the analysis of over 550 su...
https://www.medpagetoday.com/gastroenterology/generalgastroenterology/97151
Feb 11th, 2022 - A case-control study revealed which patients were more likely to use herbal products for irritable bowel syndrome. (BMC Gastroenterology) Diabetes following a liver transplant was linked to cancer risk, a study from Italy found. (Annals of Hepatol...
https://www.medscape.com/viewarticle/964508
Dec 10th, 2021 - NEW YORK (Reuters Health) - Immune-mediated diseases were associated with an increased risk of local and systemic cancers, as well as total cancers, in a large cohort study, supporting the role of local and systemic immunoregulation in the develop...
https://www.medscape.com/viewarticle/958220
Sep 7th, 2021 - NEW YORK (Reuters Health) - About 2% of patients with inflammatory bowel diseases (IBD) will develop primary sclerosing cholangitis (PSC), with a higher prevalence in men than women, according to a new analysis. In a paper in Gastroenterology, the...